Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034896
Filing Date
2024-11-13
Accepted
2024-11-13 16:05:34
Documents
61
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20240930_10q.htm   iXBRL 10-Q 821785
2 EXHIBIT 31.1 ex_739988.htm EX-31.1 10982
3 EXHIBIT 31.2 ex_739989.htm EX-31.2 11220
4 EXHIBIT 32.1 ex_739990.htm EX-32.1 4112
5 EXHIBIT 32.2 ex_739991.htm EX-32.2 4113
  Complete submission text file 0001437749-24-034896.txt   4088679

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcda-20240930.xsd EX-101.SCH 42952
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20240930_def.xml EX-101.DEF 262860
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20240930_lab.xml EX-101.LAB 231699
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20240930_pre.xml EX-101.PRE 289201
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20240930_cal.xml EX-101.CAL 28777
64 EXTRACTED XBRL INSTANCE DOCUMENT bcda20240930_10q_htm.xml XML 572477
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 241454061
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)